-
NIH’s Zika vaccine enters phase 2, unscathed by Trump's budget-cutting plans
fiercepharma
April 06, 2017
President Donald Trump has proposed $7 billion in spending cuts at the National Institutes of Health, but the agency's Zika vaccine effort won't be among them, at least not yet.
-
GeoVax pushes ahead in Zika vaccine realm with promising preclinical data
fiercepharma
March 22, 2017
A new Zika vaccine candidate by GeoVax showed promise in preclinical tests on mice, and the company believes it could become “the best solution” to the disease.
-
Inovio's first-in-human Zika, MERS vaccines pass early tests
fiercepharma
March 01, 2017
Inovio’s Zika and MERS vaccine candidates, both the first to undergo human testing in those diseases, have turned in some positive early data.
-
An all-in-one mosquito-borne diseases vaccine? NIH is testing a candidate
fiercepharma
February 23, 2017
One thing that Zika, malaria, West Nile fever and dengue have in common is that they’re all spread by mosquitoes, and now the NIH has launched a phase 1 trial to test a vaccine that aims to fight them all.
-
Zika Lingers in Semen for Less Time Than Thought: Study
drugs.com
February 15, 2017
New research suggests the Zika virus lingers in a man's semen no longer than three months in almost all cases.